Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis
2021-01-01 Conforti, F; Pala, L; Sala, I; Oriecuia, C; De Pas, T; Specchia, C; Graffeo, R; Pagan, E; Queirolo, P; Pennacchioli, E; Colleoni, M; Viale, G; Bagnardi, V; Gelber, Rd
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy
2022-01-01 Corti, Chiara; Conforti, Fabio; Pala, Laura; Catania, Chiara; Cocorocchio, Emilia; Ferrucci, Pier Francesco; Curigliano, Giuseppe; Queirolo, Paola; De Pas, Tommaso
Comparison of filgrastim and pegfilgrastim prophylaxis in sarcoma patients receiving highly myelosuppressive chemotherapy
2019-01-01 Tarantino, P; Zagami, P; Trillo, P; Conforti, F; Pala, L; Morganti, S; Ferraro, E; Viale, G; Duso, Ba; D'Amico, P; Marra, A; Trapani, D; De Pas, Tm
Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma
2021-01-01 Ferrucci, Pf; Pala, L; Conforti, F; Cocorocchio, E
Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML
2022-01-01 Nicosia, L.; Boffo, F. L.; Ceccacci, E.; Conforti, F.; Pallavicini, I.; Bedin, F.; Ravasio, R.; Massignani, E.; Somervaille, T. C. P.; Minucci, S.; Bonaldi, T.
Metaplastic breast cancer: Prognostic and therapeutic considerations
2021-01-01 Corso, G; Frassoni, S; Girardi, A; De Camilli, E; Montagna, E; Intra, M; Bottiglieri, L; De Scalzi, Am; Fanianos, Dm; Magnoni, F; Invento, A; Toesca, A; Conforti, F; Bagnardi, V; Viale, G; Colleoni, Ma; Veronesi, P
Targeting ALK in patients with advanced Non Small Cell Lung Cancer: Biology, diagnostic and therapeutic options
2014-01-01 Lazzari, C; Spitaleri, G; Catania, C; Barberis, M; Noberasco, C; Santarpia, M; Delmonte, A; Toffalorio, F; Conforti, F; De Pas, Tm
Dasatinib sensitises KRAS-mutant cancer cells to mitogen-activated protein kinase kinase inhibitor via inhibition of TAZ activity
2018-01-01 Rao, Gh; Kim, Ik; Conforti, F; Liu, J; Zhang, Yw; Giaccone, G
Sex-based dimorphism in the SARS-CoV2 virulence
2020-01-01 Pala, L; Conforti, F
Pathological and clinical features of enteric adenocarcinoma of the thymus. A pooled analysis of cases from a reference center and systematic review of the literature
2021-01-01 Conforti, F; Tarantino, P; Trillo, P; Pala, L; Zagami, P; Pirola, S; Di Venosa, B; Catania, C; Queirolo, P; Pennacchioli, E; Della Vigna, P; Curigliano, G; De Pas, Tm
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence
2019-01-01 Conforti, Fabio; Pala, Laura; Pagan, Eleonora; Viale, Giuseppe; Bagnardi, Vincenzo; Peruzzotti, Giulia; De Pas, Tommaso; Bianco, Nadia; Graffeo, Rossella; Rocco, Elena Guerini; Vingiani, Andrea; Gelber, Richard D; Coates, Alan S; Colleoni, Marco; Goldhirsch, Aron
Xpo1 Inhibition: A Promising Therapeutic Strategy in Thymic Epithelial Tumors
2015-01-01 Conforti, F; De Pas, T; Alberobello, A; Rao, Gh; Wang, Ys; Giaccone, G
Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapy
2020-01-01 Pala, L; Conforti, F; Goldhirsch, A
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials
2023-01-01 Pala, L; De Pas, T; Pagan, E; Sala, I; Catania, C; Zattarin, E; Arnone, P; Grassi, Mm; Colleoni, M; Wolff, Ac; Cortes, J; Piccart, M; Gelber, Rd; Viale, G; Bagnardi, V; Conforti, F
Biological and clinical features of early triple-negative invasive lobular carcinomas of the breast
2020-01-01 Conforti, F; Pala, L; Rocco, Eg; Pagan, E; Bagnardi, V; Montagna, E; Peruzzotti, G; De Pas, Tm; Fumagalli, C; Pileggi, S; Pesenti, C; Marchini, S; Marchi, C; Sapino, A; Gelber, Rd; Viale, G; Colleoni, M; Goldhirsch, A
Erlotinib Efficacy in NSCLC Patients with High Polysomy of Chromosome 7 and EGFR/KRas Wild-Type Tumors
2015-01-01 Toffalorio, F; De Marinis, F; Conforti, F; Spitaleri, G; Catania, C; Noberasco, C; Lazzari, C; Vecchio, F; Stufano, V; Barberis, M; De Pas, T
Sex-based differences of the intratumoral immune-infiltrate
2019-01-01 Conforti, F; Pala, L; Bagnardi, V; Pagan, E; Viale, G; De Pas, T; Penacchioli, E; Queirolo, P; Cocorocchio, E; Ferrucci, Pf; De Marinis, F; Albini, A; Gelber, R; Goldhirsch, A; Conforti, F
SLC6A4 promoter region methylation and socio-emotional stress response in very preterm and full-term infants
2016-01-01 Montirosso, Rosario; Provenzi, Livio; Giorda, Roberto; Fumagalli, Monica; Morandi, Francesco; Sirgiovanni, Ida; Pozzoli, Uberto; Grunau, Ruth; Oberlander, Tim F; Mosca, Fabio; Borgatti, Renato
Molecular and clinical features of second-generation anaplastic lymphoma kinase inhibitors ceritinib
2017-01-01 De Pas, T; Pala, L; Catania, C; Conforti, F; De Pas, T; Pala, L; Catania, C; Conforti, F
Editorial: Differential Efficacy of Immune Checkpoint Inhibitors due to Age and Sex Factors
2022-01-01 Chong, Pp; Rubin, Jb; Abdullah, M; Conforti, F; Klein, Sl; Liu, Wl
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis | 1-gen-2021 | Conforti, F; Pala, L; Sala, I; Oriecuia, C; De Pas, T; Specchia, C; Graffeo, R; Pagan, E; Queirolo, P; Pennacchioli, E; Colleoni, M; Viale, G; Bagnardi, V; Gelber, Rd | |
| Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy | 1-gen-2022 | Corti, Chiara; Conforti, Fabio; Pala, Laura; Catania, Chiara; Cocorocchio, Emilia; Ferrucci, Pier Francesco; Curigliano, Giuseppe; Queirolo, Paola; De Pas, Tommaso | |
| Comparison of filgrastim and pegfilgrastim prophylaxis in sarcoma patients receiving highly myelosuppressive chemotherapy | 1-gen-2019 | Tarantino, P; Zagami, P; Trillo, P; Conforti, F; Pala, L; Morganti, S; Ferraro, E; Viale, G; Duso, Ba; D'Amico, P; Marra, A; Trapani, D; De Pas, Tm | |
| Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma | 1-gen-2021 | Ferrucci, Pf; Pala, L; Conforti, F; Cocorocchio, E | |
| Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML | 1-gen-2022 | Nicosia, L.; Boffo, F. L.; Ceccacci, E.; Conforti, F.; Pallavicini, I.; Bedin, F.; Ravasio, R.; Massignani, E.; Somervaille, T. C. P.; Minucci, S.; Bonaldi, T. | |
| Metaplastic breast cancer: Prognostic and therapeutic considerations | 1-gen-2021 | Corso, G; Frassoni, S; Girardi, A; De Camilli, E; Montagna, E; Intra, M; Bottiglieri, L; De Scalzi, Am; Fanianos, Dm; Magnoni, F; Invento, A; Toesca, A; Conforti, F; Bagnardi, V; Viale, G; Colleoni, Ma; Veronesi, P | |
| Targeting ALK in patients with advanced Non Small Cell Lung Cancer: Biology, diagnostic and therapeutic options | 1-gen-2014 | Lazzari, C; Spitaleri, G; Catania, C; Barberis, M; Noberasco, C; Santarpia, M; Delmonte, A; Toffalorio, F; Conforti, F; De Pas, Tm | |
| Dasatinib sensitises KRAS-mutant cancer cells to mitogen-activated protein kinase kinase inhibitor via inhibition of TAZ activity | 1-gen-2018 | Rao, Gh; Kim, Ik; Conforti, F; Liu, J; Zhang, Yw; Giaccone, G | |
| Sex-based dimorphism in the SARS-CoV2 virulence | 1-gen-2020 | Pala, L; Conforti, F | |
| Pathological and clinical features of enteric adenocarcinoma of the thymus. A pooled analysis of cases from a reference center and systematic review of the literature | 1-gen-2021 | Conforti, F; Tarantino, P; Trillo, P; Pala, L; Zagami, P; Pirola, S; Di Venosa, B; Catania, C; Queirolo, P; Pennacchioli, E; Della Vigna, P; Curigliano, G; De Pas, Tm | |
| Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence | 1-gen-2019 | Conforti, Fabio; Pala, Laura; Pagan, Eleonora; Viale, Giuseppe; Bagnardi, Vincenzo; Peruzzotti, Giulia; De Pas, Tommaso; Bianco, Nadia; Graffeo, Rossella; Rocco, Elena Guerini; Vingiani, Andrea; Gelber, Richard D; Coates, Alan S; Colleoni, Marco; Goldhirsch, Aron | |
| Xpo1 Inhibition: A Promising Therapeutic Strategy in Thymic Epithelial Tumors | 1-gen-2015 | Conforti, F; De Pas, T; Alberobello, A; Rao, Gh; Wang, Ys; Giaccone, G | |
| Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapy | 1-gen-2020 | Pala, L; Conforti, F; Goldhirsch, A | |
| Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials | 1-gen-2023 | Pala, L; De Pas, T; Pagan, E; Sala, I; Catania, C; Zattarin, E; Arnone, P; Grassi, Mm; Colleoni, M; Wolff, Ac; Cortes, J; Piccart, M; Gelber, Rd; Viale, G; Bagnardi, V; Conforti, F | |
| Biological and clinical features of early triple-negative invasive lobular carcinomas of the breast | 1-gen-2020 | Conforti, F; Pala, L; Rocco, Eg; Pagan, E; Bagnardi, V; Montagna, E; Peruzzotti, G; De Pas, Tm; Fumagalli, C; Pileggi, S; Pesenti, C; Marchini, S; Marchi, C; Sapino, A; Gelber, Rd; Viale, G; Colleoni, M; Goldhirsch, A | |
| Erlotinib Efficacy in NSCLC Patients with High Polysomy of Chromosome 7 and EGFR/KRas Wild-Type Tumors | 1-gen-2015 | Toffalorio, F; De Marinis, F; Conforti, F; Spitaleri, G; Catania, C; Noberasco, C; Lazzari, C; Vecchio, F; Stufano, V; Barberis, M; De Pas, T | |
| Sex-based differences of the intratumoral immune-infiltrate | 1-gen-2019 | Conforti, F; Pala, L; Bagnardi, V; Pagan, E; Viale, G; De Pas, T; Penacchioli, E; Queirolo, P; Cocorocchio, E; Ferrucci, Pf; De Marinis, F; Albini, A; Gelber, R; Goldhirsch, A; Conforti, F | |
| SLC6A4 promoter region methylation and socio-emotional stress response in very preterm and full-term infants | 1-gen-2016 | Montirosso, Rosario; Provenzi, Livio; Giorda, Roberto; Fumagalli, Monica; Morandi, Francesco; Sirgiovanni, Ida; Pozzoli, Uberto; Grunau, Ruth; Oberlander, Tim F; Mosca, Fabio; Borgatti, Renato | |
| Molecular and clinical features of second-generation anaplastic lymphoma kinase inhibitors ceritinib | 1-gen-2017 | De Pas, T; Pala, L; Catania, C; Conforti, F; De Pas, T; Pala, L; Catania, C; Conforti, F | |
| Editorial: Differential Efficacy of Immune Checkpoint Inhibitors due to Age and Sex Factors | 1-gen-2022 | Chong, Pp; Rubin, Jb; Abdullah, M; Conforti, F; Klein, Sl; Liu, Wl |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26266
Data di pubblicazione
- In corso di stampa10
- 2020 - 20268444
- 2010 - 201911540
- 2000 - 20094513
- 1990 - 19991428
- 1980 - 1989308
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE358
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...259
- ANNALS OF ONCOLOGY239
- CANCERS223
- THE JOURNAL OF NUCLEAR MEDICINE221
- PLOS ONE211
- EUROPEAN JOURNAL OF CANCER197
- GASTROINTESTINAL ENDOSCOPY193
- ALLERGY178
- JOURNAL OF CLINICAL ONCOLOGY169
Keyword
- Humans2102
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19408
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng18439
- ita405
- spa13
- fre11
- ger8
- enm3
- por2
- chi1
- und1
Accesso al fulltext
- no fulltext24066
- reserved1312
- open888